Skip to main content

Axogen Inc

For the period ended Dec 31, 2023. Filed Mar 5, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Mar 5, 2024

AXGN$50.64+1.2%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

SCHEDULE II VALUATION AND QUALIFYING ACCOUNTS

SCHEDULE II – VALUATION AND QUALIFYING ACCOUNTS

THREE YEARS ENDED DECEMBER 31, 2023, 2022 AND 2021

(in thousands) · Balance at Beginning of Year · Additions · Deductions (Charge-offs) · Balance at End of Year
Allowance for doubtful accounts
2021$416$—$(140)$276
2022$276$612$(238)$650
2023$650$—$(313)$337
Valuation allowance for deferred tax assets
2021$46,517$6,734$53,251
2022$53,251$5,058$—$58,309
2023$58,309$2,831$—$61,140
Valuation for inventory reserves
2021$1,553$3,314$(2,291)$2,576
20222,5761,769(2,410)1,935
20231,9351,939(2,533)1,342
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.